SEI Investments’s Cellectis CLLS Stock Holding History

SEI Investments’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,977	Closed	-$25K	–	2553
2022 Q3	$25K	Buy	+10,977	New	+$33.3K	﹤0.01%	2640
2018 Q4	–	Sell	-421	Closed	-$9K	–	2634
2018 Q3	$9K	Sell	421 -254	-38%	-$7.3K	﹤0.01%	2426
2018 Q2	$19K	Buy	+675	New	+$20.1K	﹤0.01%	2811

Other funds holding CLLS

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SEI Investments's CLLS Position: Q4 2022 in Review

SEI Investments sold out of Cellectis (CLLS) in Q4 2022, closing a stake of 10,977 shares — an estimated $25K sold.

SEI Investments first reported a position in CLLS in Q2 2018 and held it in 3 quarters. The position peaked at $25K in Q3 2022. 40 funds tracked by Wall St. Rank hold CLLS as of Q4 2022.

SEI Investments reported no remaining Cellectis position as of Q4 2022 after selling out during the quarter.
SEI Investments sold 10,977 Cellectis shares in Q4 2022, an estimated $25K.
SEI Investments first reported a position in Cellectis in Q2 2018 and held it in 3 quarters.
SEI Investments's Cellectis position peaked at $25K in Q3 2022.
40 funds tracked by Wall St. Rank held Cellectis as of Q4 2022.

Based on SEI Investments's 13F filing for Q4 2022, filed 10 Feb 2023.